LINAGLIPTIN

UNII:	3X29ZEJ4R2
Formula:	C₂₅H₂₈N₈O₂
Preferred Substance Name:	LINAGLIPTIN
InChIKey:	LTXREWYXXSTFRX-QGZVFWFLSA-N

668270-12-0
(R)-8-(3-AMINO-PIPERIDIN-1-YL)-7-BUT-2-YNYL-3-METHYL-1-(4-METHYL-QUINAZOLIN-2-YLMETHYL)-3,7-DIHYDRO-PURINE-2,6-DIONE
1H-PURINE-2,6-DIONE, 8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYN-1-YL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-
1H-PURINE-2,6-DIONE, 8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYNYL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-
8-((3R)-3-AMINOPIPERIDIN-1-YL)-7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
BI 1356
BI 1356 BS
BI1356
BI-1356
BI-1356BS
BI-1356-BS
BS 1356 BS
BS-1356-BS
GLYXAMBI COMPONENT LINAGLIPTIN
LINAGLIPTIN [INN]
LINAGLIPTIN [JAN]
LINAGLIPTIN [MART.]
LINAGLIPTIN [MI]
LINAGLIPTIN [ORANGE BOOK]
LINAGLIPTIN [USAN]
LINAGLIPTIN [VANDF]
LINAGLIPTIN [WHO-DD]
TRAJENTA
TRAZENTA
TRIJARDY XR COMPONENT LINAGLIPTIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LINAGLIPTIN

Synonyms and Mappings

Resources